| ¿µ¹® | sleep | ÇÑ±Û | Àá, ¼ö¸é |
|---|---|---|---|
| ¼³¸í | ÀÇÁöÀÛ¿ë ¹× ÀǽÄÀÌ ºÎºÐÀûÀ¸·Î ¶Ç´Â ¿ÏÀüÈ÷ Á¤ÁöµÇ°í ½ÅüÀû ±â´ÉÀÌ ºÎºÐÀûÀ¸·Î Á¤ÁöµÇ´Â ¸ö°ú ¸¶À½ÀÇ »óÅÂ. ¼ö¸éÀº ÀÔ¸é±â, °¡º¿î ¼ö¸é±â, ±íÀº ¼ö¸é±â, ·½¼ö¸é±âÀÇ 4»óÀ¸·Î ³ª´µ¾î ÀÖ´Ù. ±íÀº ¼ö¸é¿¡¼ ·½¼ö¸é±îÁöÀÇ Áֱ⸦ ¼ö¸éÁÖ±â¶ó°í ÇÏ¸ç ¾à 90ºÐÀÇ ÁÖ±â·Î ÇÏ·ç¿¡ 4~5ȸ µÇÇ®À̵ȴÙ. ¼ö¸éÀÇ ÁÖ±â´Â ³ú³»ÀÇ ¼ö¸éÀ» ÀÏÀ¸Å°´Â ±â±¸¿Í °¢¼ºÀ» ÀÏÀ¸Å°´Â ±â±¸°¡ ¹ø°¥¾Æ ÀÛµ¿Çؼ Çü¼ºµÇ°í ÀÖ´Ù. ¾ÆÄ§¿¡ ´«À» ¶°¼ ¹ã¿¡ Àáµç´Ù´Â ±âº»ÀûÀÎ ÀÏÁֱ⠸®µëÀº ½Ã»óÇϺÎÀÇ ½Ã°¢±³Â÷À§ÇÙ¿¡ ÀÇÇØ¼ ¾ïÁ¦µÇ°í ÀÖ´Ù. ¼ö¸é½Ã°£Àº ½Å»ý¾Æ¿¡¼ ¾à 15½Ã°£ÀÌ ³ª ÀÖÀ¸³ª ¼ºÀο¡¼ ¾à 8½Ã°£, ³ëÀÎÀÌ µÇ¸é ¾à 6½Ã°£ Á¤µµÀÌ´Ù. ·½¼ö¸éÀº ½Å»ý¾Æ¿¡¼ ¾à 8½Ã°£À̳ª µÇÁö¸¸ Ãâ»ý ÈÄ 2³â°ºÎÅÍ ±Þ°ÝÈ÷ °¨¼ÒÇÑ´Ù. ¼ö¸é·®Àº »ýÁã µîÀÇ »ê¼Ò¼Òºñ·®ÀÌ ¸¹Àº µ¿¹°Àϼö·Ï ±æ°í ÄÚ³¢¸®¿Í °°Àº ÀûÀº µ¿¹°Àϼö·Ï ª´Ù. ¼ö¸éÀº ¿¡³ÊÁö¼Òºñ·®ÀÇ ÀúÇϳª Á¤»óÁ¤½Å»óÅÂÀÇ À¯Áö¿¡µµ °ü¿©ÇÑ´Ù°í »ý°¢µÇ°í ÀÖ´Ù. |
||
| rem | Roentgen Equivalent Man 1 rem = 1 rad x RBE |
|---|---|
| LPF | leukocytosis-promoting factor; leukopenia factor; lipopolysaccharide factor; localized plaque format... |
| non-REM | non-rapid eye movement [sleep] |
| SPS | Sleep Promoting Substance |
| DS | dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul... |
| REM SD | REM sleep deprivation |
|---|---|
| NREMS | Non-REM sleep |
| RSD | REM sleep deprivation |
| REMS | REM sleep |
| RBD | REM sleep behavior disorder |
| REM stage sleep | <physiology> A stage of deep sleep that is accompanied by rapid eye movement and muscle paralysis. Vivid dreams can be recalled in over 80% of patients who awake from REM stage sleep. (27 Sep 1997) |
|---|---|
| sleep, rem | A stage of sleep characterised by rapid movements of the eye and low voltage fast pattern eeg. It is usually associated with dreaming. (12 Dec 1998) |
| maturation-promoting factor | <enzyme> A protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms. In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by cyclins, maturation-promoting factor directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins. The catalytic subunit of maturation-promoting factor is protein p34cdc2. Acronym: MPF (12 Dec 1998) |
| M phase promoting factor | Protein whose levels rise rapidly just before and fall away just after, mitosis. Thought to be a trigger for mitosis. (18 Nov 1997) |
| leukocytosis-promoting factor | A substance obtained by Menkin from inflammatory exudates; it stimulates leukocytosis. (05 Mar 2000) |
| REM | <radiobiology> The conventional unit of dose equivalent. The dose equivalent in rem is numerically equal to the absorbed dose, D, in rad multiplied by the quality factor Q. 1 rem = 0.01 sievert. (See sievert, rad). Note: for most medical applications involving X-ray or gamma emitters, the numerical values of the absorbed dose in rad, dose equivalent in rem and exposure in R are roughly equivalent numerically. (16 Dec 1997) |
| REM behaviour disorder | A disorder characterised by lack of the atonia of voluntary muscles that normally occurs in REM sleep. (05 Mar 2000) |
| REM syndrome | <syndrome> A reticular erythematous dermatitis of the upper trunk, more common in women, in which there is perivascular infiltrate of lymphocytes, few plasma cells, and upper dermal deposits of mucin; worsens on exposure to ultraviolet light. Synonym: reticular erythematous mucinosis. (05 Mar 2000) |
| rapid eye movement sleep | REM sleep, that state of deep sleep in which rapid eye movements, alert EEG pattern, and dreaming occur; several central and autonomic functions are distinctive during this state. (05 Mar 2000) |
| paradoxical sleep | A deep sleep, with a brain wave pattern more like that of waking states than of other states of sleep, which occurs during rapid eye movement sleep. (05 Mar 2000) |
| paroxysmal sleep | <neurology> A disorder of sleep associated with excessive daytime sleepiness, involuntary daytime sleep episodes, disturbed nocturnal sleep and cataplexy. Narcolepsy affects over 100,000 people in the United States and appears to have a genetic basis. Symptoms usually begin in the patients twenties. Treatment often includes the use of amphetamines and-or tricyclic antidepressants. (27 Sep 1997) |
| central sleep apnoea | <neurology> A form of sleep apnoea which from the lack of neurologic stimulation to breathe. (12 Jan 1998) |
| mixed sleep apnoea | <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes. (13 Nov 1997) |
| winter sleep | The dormant state in which some animal species pass the winter. It is characterised by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs. It is a natural physiological process in many warm-blooded animals. (12 Dec 1998) |
| multiple sleep latency test | A test of the propensity to fall asleep, done by performing polysomnography during multiple brief opportunities to sleep. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|